| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.008 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |